FDA Clearance Tracker · P110001-S009
RX HERCULINK ELITE RENAL STENT SYSTEM
Last checked: Nov 20, 2026Latest source record: Oct 9, 2012 (this decision)Source: openFDAMethods & limitations
Decided
Oct 9, 2012
Approved
Time to decision
68 days
Received Aug 2, 2012. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P110001-S009
- Device name
- RX HERCULINK ELITE RENAL STENT SYSTEM
- Applicant
- Abbott Vascular
- Applicant location
- Santa Clara, CA
- Received
- Aug 2, 2012
- Decided
- Oct 9, 2012
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P110001
Device type
- Device type
- STENT, RENAL (NIN)
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR A MANUFACTURING SITE LOCATED AT ABBOTT VASCULAR CARDIAC THERAPIES IN CLONMEL, IRELAND.
Source documents
Other decisions for Abbott Vascular
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- XACT Carotid Stent SystemPMA supplement
P040038-S043 · Decided Feb 7, 2024 · 225 days after receipt · Panel Track
Device type: Stent, carotid (NIM) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.